ScreenFect GmbH is a biotech company founded in Germany in 2012 (formerly Incella GmbH). The company focuses on the development of novel gene- and drug-delivery systems. The company is using its proprietary lipid synthesis technology to synthesize libraries of different lipids, followed by their high-throughput screening with live cells in order to identify novel highly efficient and non-toxic gene-delivery systems.